FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2023821799> ?p ?o ?g. }

• W2023821799 endingPage "1641" @default.
• W2023821799 startingPage "1635" @default.
• W2023821799 abstract "Objective To evaluate overall survival (OS) and progression-free survival (PFS) after adjuvant therapy in stage I to stage IV uterine carcinosarcoma with rhabdomyosarcoma differentiation. Methods Memorial Sloan-Kettering Cancer Center medical records from 1990 to 2012 were reviewed. Patients who received chemotherapy with or without radiation therapy (RT), or RT alone, for completely resected stage I to stage IV uterine carcinosarcoma with rhabdomyosarcoma differentiation were included. Results Of 53 patients, International Federation of Gynecology and Obstetrics stage distribution was as follows: I, 13 (24.5%); II, 8 (15.1%); III, 13 (24.5%); and IV, 19 (35.9%). Forty-one (77.4%) of 53 patients received adjuvant chemotherapy, and 34% of the patients who received chemotherapy also received pelvic RT or intravaginal brachytherapy (IVRT). Twelve (22.6%) of the 53 patients received only pelvic RT with/without IVRT. Paclitaxel-carboplatin was the most commonly used adjuvant chemotherapy treatment. The median PFS for the entire cohort was 13.4 months (95% confidence interval [CI], 10.5–17.0). The median OS for the entire cohort was 23.0 months (95% CI, 16.9–34.3). The median PFS periods by stage were 15.9 months for stages I/II versus 11.2 months for stages III/IV ( P = 0.012). Median OS was not reached in the early-stage cohort. The median OS for the late-stage cohort was 20.9 months ( P = 0.004). The median PFS periods by treatment were 10.4 months for pelvic RT with/without IVRT group versus 13.1 months for chemotherapy with/without pelvic RT with/without IVRT group ( P = 0.498). The median OS periods by treatment were 23.6 months for chemotherapy with/without pelvic RT with/without IVRT group versus 16.9 months for pelvic RT with/without IVRT group ( P = 0.501). Conclusion The results suggest that chemotherapy alone or in combination with RT is associated with longer PFS and OS compared to RT alone. Only the stage of disease significantly affected PFS and OS." @default.
• W2023821799 created "2016-06-24" @default.
• W2023821799 creator A5001429608 @default.
• W2023821799 creator A5026372438 @default.
• W2023821799 creator A5032196793 @default.
• W2023821799 creator A5046393441 @default.
• W2023821799 creator A5054309501 @default.
• W2023821799 creator A5054602117 @default.
• W2023821799 creator A5069757930 @default.
• W2023821799 creator A5074877517 @default.
• W2023821799 creator A5085163128 @default.
• W2023821799 date "2013-11-01" @default.
• W2023821799 modified "2023-09-22" @default.
• W2023821799 title "Treatment Outcomes in Completely Resected Stage I to Stage IV Uterine Carcinosarcoma With Rhabdomyosarcoma Differentiation" @default.
• W2023821799 cites W1489305676 @default.
• W2023821799 cites W1966048683 @default.
• W2023821799 cites W1986822666 @default.
• W2023821799 cites W1988484990 @default.
• W2023821799 cites W2000826244 @default.
• W2023821799 cites W2023568044 @default.
• W2023821799 cites W2058979613 @default.
• W2023821799 cites W2071419267 @default.
• W2023821799 cites W2073547414 @default.
• W2023821799 cites W2075431172 @default.
• W2023821799 cites W2158525277 @default.
• W2023821799 cites W2315907200 @default.
• W2023821799 cites W4322699981 @default.
• W2023821799 doi "https://doi.org/10.1097/igc.0000000000000001" @default.
• W2023821799 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24172099" @default.
• W2023821799 hasPublicationYear "2013" @default.
• W2023821799 type Work @default.
• W2023821799 sameAs 2023821799 @default.
• W2023821799 citedByCount "4" @default.
• W2023821799 countsByYear W20238217992015 @default.
• W2023821799 countsByYear W20238217992016 @default.
• W2023821799 countsByYear W20238217992022 @default.
• W2023821799 crossrefType "journal-article" @default.
• W2023821799 hasAuthorship W2023821799A5001429608 @default.
• W2023821799 hasAuthorship W2023821799A5026372438 @default.
• W2023821799 hasAuthorship W2023821799A5032196793 @default.
• W2023821799 hasAuthorship W2023821799A5046393441 @default.
• W2023821799 hasAuthorship W2023821799A5054309501 @default.
• W2023821799 hasAuthorship W2023821799A5054602117 @default.
• W2023821799 hasAuthorship W2023821799A5069757930 @default.
• W2023821799 hasAuthorship W2023821799A5074877517 @default.
• W2023821799 hasAuthorship W2023821799A5085163128 @default.
• W2023821799 hasConcept C126322002 @default.
• W2023821799 hasConcept C141071460 @default.
• W2023821799 hasConcept C142724271 @default.
• W2023821799 hasConcept C143998085 @default.
• W2023821799 hasConcept C146357865 @default.
• W2023821799 hasConcept C151730666 @default.
• W2023821799 hasConcept C2776694085 @default.
• W2023821799 hasConcept C2777546739 @default.
• W2023821799 hasConcept C2778239845 @default.
• W2023821799 hasConcept C2778256501 @default.
• W2023821799 hasConcept C2778938455 @default.
• W2023821799 hasConcept C2780844630 @default.
• W2023821799 hasConcept C2781451048 @default.
• W2023821799 hasConcept C71924100 @default.
• W2023821799 hasConcept C72563966 @default.
• W2023821799 hasConcept C86803240 @default.
• W2023821799 hasConceptScore W2023821799C126322002 @default.
• W2023821799 hasConceptScore W2023821799C141071460 @default.
• W2023821799 hasConceptScore W2023821799C142724271 @default.
• W2023821799 hasConceptScore W2023821799C143998085 @default.
• W2023821799 hasConceptScore W2023821799C146357865 @default.
• W2023821799 hasConceptScore W2023821799C151730666 @default.
• W2023821799 hasConceptScore W2023821799C2776694085 @default.
• W2023821799 hasConceptScore W2023821799C2777546739 @default.
• W2023821799 hasConceptScore W2023821799C2778239845 @default.
• W2023821799 hasConceptScore W2023821799C2778256501 @default.
• W2023821799 hasConceptScore W2023821799C2778938455 @default.
• W2023821799 hasConceptScore W2023821799C2780844630 @default.
• W2023821799 hasConceptScore W2023821799C2781451048 @default.
• W2023821799 hasConceptScore W2023821799C71924100 @default.
• W2023821799 hasConceptScore W2023821799C72563966 @default.
• W2023821799 hasConceptScore W2023821799C86803240 @default.
• W2023821799 hasIssue "9" @default.
• W2023821799 hasLocation W20238217991 @default.
• W2023821799 hasLocation W20238217992 @default.
• W2023821799 hasOpenAccess W2023821799 @default.
• W2023821799 hasPrimaryLocation W20238217991 @default.
• W2023821799 hasRelatedWork W1481820868 @default.
• W2023821799 hasRelatedWork W2053778437 @default.
• W2023821799 hasRelatedWork W2060767396 @default.
• W2023821799 hasRelatedWork W2072767112 @default.
• W2023821799 hasRelatedWork W2076107896 @default.
• W2023821799 hasRelatedWork W2105623825 @default.
• W2023821799 hasRelatedWork W2157919202 @default.
• W2023821799 hasRelatedWork W2349339246 @default.
• W2023821799 hasRelatedWork W2471989939 @default.
• W2023821799 hasRelatedWork W4296767593 @default.
• W2023821799 hasVolume "23" @default.
• W2023821799 isParatext "false" @default.
• W2023821799 isRetracted "false" @default.
• W2023821799 magId "2023821799" @default.
• W2023821799 workType "article" @default.